医学
危险系数
内科学
肾细胞癌
置信区间
优势比
比例危险模型
生物标志物
中性粒细胞与淋巴细胞比率
前瞻性队列研究
肿瘤科
胃肠病学
无进展生存期
泌尿科
淋巴细胞
总体生存率
生物化学
化学
作者
Arnoud J. Templeton,Jennifer Jane Knox,Xun Lin,Ronit Simantov,Wanling Xie,Nicola Jane Lawrence,Reuben James Broom,André P. Fay,Brian I. Rini,Frede N. Donskov,Georg A. Bjarnason,Martin Smoragiewicz,Christian Kollmannsberger,Ravindran Kanesvaran,Nimira S. Alimohamed,Thomas Hermanns,John Connor Wells,Eitan Amir,Toni K. Choueiri,Daniel Yick Chin Heng
标识
DOI:10.1016/j.eururo.2016.02.033
摘要
BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR), if elevated, is associated with worse outcomes in several malignancies. OBJECTIVE: Investigation of NLR at baseline and during therapy for metastatic renal cell carcinoma. DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of 1199 patients from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC cohort) and 4350 patients from 12 prospective randomized trials (validation cohort). INTERVENTION: Targeted therapies for metastatic renal cell carcinoma. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: NLR was examined at baseline and 6 (± 2) wk later. A landmark analysis at 8 wk was conducted to explore the prognostic value of relative NLR change on overall survival (OS), progression-free survival (PFS), and objective response rate using Cox or logistic regression models, adjusted for variables in IMDC score and NLR values at baseline. RESULTS AND LIMITATIONS: Higher NLR at baseline was associated with shorter OS and PFS (Hazard Ratios [HR] per 1 unit increase in log-transformed NLR = 1.69 [95% confidence interval {CI} = 1.46-1.95] and 1.30 [95% CI = 1.15-1.48], respectively). Compared with no change (decrease < 25% to increase < 25%, reference), increase NLR at Week 6 by 25-50% and > 75% was associated with poor OS (HR=1.55 [95% CI=1.10-2.18] and 2.31 [95% CI=1.64-3.25], respectively), poor PFS (HR=1.46 [95% CI=1.04-2.03], 1.76 [95% CI=1.23-2.52], respectively), and reduced objective response rate (odds ratios = 0.77 [95% CI=0.37-1.63] and 0.24 [95% CI=0.08-0.72], respectively). By contrast, a decrease of 25-50% was associated with improved outcomes. Findings were confirmed in the validation cohort. The study is limited by its retrospective design. CONCLUSIONS: Compared with no change, early decline of NLR is associated with favorable outcomes, whereas an increase is associated with worse outcomes. PATIENT SUMMARY: We found that the proportion of immune cells in the blood is of prognostic value, namely that a decrease of the proportion of neutrophils-to-lymphocytes is associated with more favorable outcomes while an increase had the opposite effect.
科研通智能强力驱动
Strongly Powered by AbleSci AI